|
rdf:type |
|
|
lifeskim:mentions |
|
|
pubmed:issue |
9
|
|
pubmed:dateCreated |
2006-8-30
|
|
pubmed:abstractText |
Resistance to beta-lactams and quinolones in two isogenic Enterobacter cloacae isolates was studied. One was susceptible to cefoxitin and amoxicillin-clavulanate. The other one showed its natural beta-lactam resistance pattern. Both isolates had a nonfunctional AmpR regulator. However, within the second one, the presence of a plasmid carrying ampR and qnrA1 allowed reversion to the wild-type beta-lactam resistance phenotype and decreased susceptibility to fluoroquinolones.
|
|
pubmed:commentsCorrections |
http://linkedlifedata.com/resource/pubmed/commentcorrection/16940123-10539994,
http://linkedlifedata.com/resource/pubmed/commentcorrection/16940123-10681318,
http://linkedlifedata.com/resource/pubmed/commentcorrection/16940123-10858363,
http://linkedlifedata.com/resource/pubmed/commentcorrection/16940123-11709308,
http://linkedlifedata.com/resource/pubmed/commentcorrection/16940123-11909836,
http://linkedlifedata.com/resource/pubmed/commentcorrection/16940123-12039891,
http://linkedlifedata.com/resource/pubmed/commentcorrection/16940123-12821475,
http://linkedlifedata.com/resource/pubmed/commentcorrection/16940123-14757240,
http://linkedlifedata.com/resource/pubmed/commentcorrection/16940123-15956430,
http://linkedlifedata.com/resource/pubmed/commentcorrection/16940123-1762913,
http://linkedlifedata.com/resource/pubmed/commentcorrection/16940123-7574506,
http://linkedlifedata.com/resource/pubmed/commentcorrection/16940123-7925310,
http://linkedlifedata.com/resource/pubmed/commentcorrection/16940123-8452343,
http://linkedlifedata.com/resource/pubmed/commentcorrection/16940123-8559061,
http://linkedlifedata.com/resource/pubmed/commentcorrection/16940123-9118225,
http://linkedlifedata.com/resource/pubmed/commentcorrection/16940123-9372424,
http://linkedlifedata.com/resource/pubmed/commentcorrection/16940123-9579076
|
|
pubmed:language |
eng
|
|
pubmed:journal |
|
|
pubmed:citationSubset |
IM
|
|
pubmed:chemical |
|
|
pubmed:status |
MEDLINE
|
|
pubmed:month |
Sep
|
|
pubmed:issn |
0066-4804
|
|
pubmed:author |
|
|
pubmed:issnType |
Print
|
|
pubmed:volume |
50
|
|
pubmed:owner |
NLM
|
|
pubmed:authorsComplete |
Y
|
|
pubmed:pagination |
3175-8
|
|
pubmed:dateRevised |
2009-11-18
|
|
pubmed:meshHeading |
pubmed-meshheading:16940123-Amoxicillin-Potassium Clavulanate Combination,
pubmed-meshheading:16940123-Bacterial Proteins,
pubmed-meshheading:16940123-Cefoxitin,
pubmed-meshheading:16940123-Enterobacter cloacae,
pubmed-meshheading:16940123-Enterobacteriaceae Infections,
pubmed-meshheading:16940123-Humans,
pubmed-meshheading:16940123-Microbial Sensitivity Tests,
pubmed-meshheading:16940123-Plasmids,
pubmed-meshheading:16940123-Polymerase Chain Reaction,
pubmed-meshheading:16940123-Quinolones,
pubmed-meshheading:16940123-beta-Lactam Resistance
|
|
pubmed:year |
2006
|
|
pubmed:articleTitle |
In vivo reversion to the wild-type beta-lactam resistance phenotype mediated by a plasmid carrying ampR and qnrA1 in Enterobacter cloacae.
|
|
pubmed:affiliation |
Servicio de Microbiología, Hospital Vall d'Hebron, Universitat Autònoma de Barcelona, Spain.
|
|
pubmed:publicationType |
Journal Article,
Research Support, Non-U.S. Gov't
|
